Primary Health Properties (PHP) Share Price, News & Analysis

Company Overview

Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.

Key Stats

• Today's Range: 90.80 to 94.65
• 50-Day Range: 92.50 to 102.30
• 52-Week Range: 86.25 to 109
• Volume: 1.14 million shs
• Average Volume: 4.12 million shs
• Market Capitalization: £1.25 billion
• P/E Ratio: N/A
• Dividend Yield: 7.49%
• Price Target: GBX 107.50
• Consensus Rating: Moderate Buy

Primary Health Properties Stock Analysis - MarketRank™

Primary Health Properties scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Primary Health Properties has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Primary Health Properties has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Primary Health Properties is -9,340.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Primary Health Properties is -9,340.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Primary Health Properties has a PEG Ratio of 5.64. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Primary Health Properties has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for PHP.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Primary Health Properties is a leading dividend payer. It pays a dividend yield of 7.11%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Primary Health Properties does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for PHP.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Primary Health Properties this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for PHP on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Primary Health Properties insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.81% of the stock of Primary Health Properties is held by insiders.

Percentage Held by Institutions

70.56% of the stock of Primary Health Properties is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PHP Stock Analysis - Frequently Asked Questions

How have PHP shares performed this year?

Primary Health Properties' stock was trading at GBX 103.80 at the start of the year. Since then, PHP shares have decreased by 10.0% and is now trading at GBX 93.40.
View the best growth stocks for 2024 here.

How were Primary Health Properties' earnings last quarter?

Primary Health Properties Plc (LON:PHP) posted its earnings results on Thursday, January, 31st. The real estate investment trust reported $5.20 earnings per share for the quarter, missing the consensus estimate of $5.30 by $0.10. Primary Health Properties had a negative net margin of 4.84% and a negative trailing twelve-month return on equity of 0.60%.

How do I buy shares of Primary Health Properties?

Shares of PHP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Primary Health Properties own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Primary Health Properties investors own include Lloyds Banking Group (LLOY), Meta Platforms (META), Aviva (AV), Barclays (BARC), BP (BP), Legal & General Group (LGEN) and Barratt Developments (BDEV).

Company Calendar

• Last Earnings: 1/31/2019
• Ex-Dividend for 11/22 Dividend: 10/10/2024
• Today: 11/21/2024
• Dividend Payable: 11/22/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: LON:PHP
• CUSIP: N/A
• CIK: N/A
• Web: www.phpgroup.co.uk
• Phone: +44-20-71045599
• Fax: N/A
• Employees: 58
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 107.50
• High Stock Price Target: GBX 110
• Low Stock Price Target: GBX 105
• Potential Upside/Downside: +15.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 13.18
• P/E Growth: 5.64
• Net Income: £-8,600,000.00
• Net Margins: -4.84%
• Pretax Margin: N/A
• Return on Equity: -0.60%
• Return on Assets: 3.08%

Debt

• Debt-to-Equity Ratio: 96.98
• Current Ratio: 0.48
• Quick Ratio: 0.62

Sales & Book Value

• Annual Sales: £177.80 million
• Price / Sales: 7.04
• Cash Flow: GBX 1.88 per share
• Price / Cash Flow: 49.77
• Book Value: GBX 103 per share
• Price / Book: 0.91

Miscellaneous

• Outstanding Shares: 1,340,000,000
• Free Float: N/A
• Market Cap: £1.25 billion
• Optionable: Not Optionable
• Beta: 0.41